Search results for "Chronic kidney disease"
Residents reimagine antiracism curriculum
Residents interested in diversity, equity, and inclusion are taking matters into their own hands, creating new training initiatives about the subject as a formal part of their medical school curriculum.
https://immattersacp.org/archives/2021/07/residents-reimagine-antiracism-curriculum.htm
1 Jul 2021
Pacemakers, stents recalled; warnings on liver disease drug
This column reviews details on recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2021/07/pacemakers-stents-recalled-warnings-on-liver-disease-drug.htm
1 Jul 2021
Guideline issued on blood pressure management in CKD
The Kidney Disease: Improving Global Outcomes Work Group recommends targeting a standardized systolic blood pressure less than 120 mm Hg in patients with chronic kidney disease (CKD) who are not receiving dialysis, among other guidance.
https://immattersacp.org/weekly/archives/2021/06/22/4.htm
22 Jun 2021
New recommendations advise on adding SGLT-2 inhibitors and GLP-1 receptor agonists
A new guideline from The BMJ strongly recommends sodium-glucose cotransporter-2 (SGLT-2) inhibitors for patients with diabetes and established cardiovascular and chronic kidney disease, among other advice.
https://immattersacp.org/weekly/archives/2021/05/18/4.htm
18 May 2021
Correcting medicine's use of race in clinical algorithms
Recent efforts have pushed institutions to reconsider the use of race not just in estimating kidney function, but in a variety of algorithms and scores.
https://immattersacp.org/archives/2021/05/correcting-medicines-use-of-race-in-clinical-algorithms.htm
1 May 2021
Racial, economic disparities found in use of SGLT-2 inhibitors
Although use of sodium-glucose cotransporter-2 (SGLT-2) inhibitors rose overall between 2015 and 2019, patients who were Black, Asian, female, or with lower household income had lower rates of prescriptions for the drug class than others with type 2 diabetes.
https://immattersacp.org/weekly/archives/2021/04/20/2.htm
20 Apr 2021
FDA OKs marketing of devices for snoring, brain protection
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2021/04/fda-oks-marketing-of-devices-for-snoring-brain-protection.htm
1 Apr 2021
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2021/03/latest-updates-on-acps-priorities-initiatives.htm
1 Mar 2021
Inappropriate medications prescribed in some Medicare patients with CKD, study finds
Over a third of patients with chronic kidney disease (CKD) enrolled in a Medicare plan's Medication Therapy Management program in 2018 received a prescription for at least one potentially inappropriate medication.
https://immattersacp.org/weekly/archives/2021/02/02/5.htm
2 Feb 2021
Getting dialysis for undocumented patients
Undocumented immigrants in the U.S. with end-stage kidney disease (ESKD) number in the thousands, and new programs and policies are allowing them to tap into dialysis before their condition warrants emergency treatment.
https://immattersacp.org/archives/2021/02/getting-dialysis-for-undocumented-patients.htm
1 Feb 2021